BioSpace News Archive

Business

TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial ResultsConference call to be held today, August 8, 2022 at 8:30 AM ET

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended June 30, 2022 and recent company developments, along with a business outlook for the remainder of 2022.

August 8, 2022
·
9 min read
Business

Annovis Bio Announces Second Quarter 2022 Results and Provides Corporate Update

Annovis Bio, Inc. today announced second quarter financial results for the quarter ended June 30, 2022, and reviewed recent accomplishments.

August 8, 2022
·
4 min read
Business

Pyramid Biosciences Names Nushmia Khokhar, MD, as Chief Medical Officer

Pyramid Biosciences, Inc. today announced the expansion of its senior leadership team. Nushmia Khokhar, MD has joined the company as Chief Medical Officer.

August 8, 2022
·
3 min read
Business

Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the second quarter ended June 30, 2022.

August 8, 2022
·
9 min read
Bio NC

150 Orphan Drug Indication Approvals Trusted to Calyx IRT

Calyx, today announced it has achieved a milestone in supporting the clinical development of approved treatments for rare diseases.

August 8, 2022
·
2 min read
Business

Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344

Cocrystal Pharma, Inc. announces it has engaged hVIVO to conduct a Phase 2a clinical trial with the Company’s novel, broad-spectrum, orally administered antiviral candidate CC- 42344.

August 8, 2022
·
5 min read
Business

Indaptus Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announces financial results for the second quarter ended June 30, 2022 and provides a corporate update.

August 8, 2022
·
12 min read
Business

Impel Pharmaceuticals to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

Impel Pharmaceuticals Inc. today announced it will host a live webcast on Monday, August 15, 2022, at 8:30 a.m. ET to report its second quarter 2022 financial results and provide a business update.

August 8, 2022
·
1 min read
Business

Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update

Gain Therapeutics, Inc. today announced its financial results for the second quarter ended June 30, 2022, and highlighted recent corporate progress.

August 8, 2022
·
11 min read
Pharm Country

RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition

RespireRx Pharmaceuticals Inc. is pleased to announce that Sleep Review Magazine has published, in its June 13, 2022 edition, a free e-book entitled “How Close Are We to Drug Therapy for Obstructive Sleep Apnea?”

August 8, 2022
·
13 min read